➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim

Last Updated: May 30, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Sitaxentan

Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Sitaxentan?

Sitaxentan is an investigational drug.

There have been 10 clinical trials for Sitaxentan. The most recent clinical trial was a Phase 3 trial, which was initiated on November 1st 2010.

The most common disease conditions in clinical trials are Hypertension, Familial Primary Pulmonary Hypertension, and Hypertension, Pulmonary. The leading clinical trial sponsors are Pfizer, Institut National de la Santé Et de la Recherche Médicale, France, and Encysive Pharmaceuticals.

Recent Clinical Trials for Sitaxentan
Drug Interaction Between Ritonavir And SitaxsentanPfizerPhase 1
Long-Term Open-Label, Safety Study Of Sitaxentan Sodium In Japanese Pulmonary Arterial Hypertension PatientsPfizerPhase 3
A Pharmacokinetic Drug-Drug Interaction (DDI) Study Between Sitaxsentan And Sildenafil, And Between Sitaxsentan And Tadalafil After Multiple DosesPfizerPhase 1

See all Sitaxentan clinical trials

Clinical Trial Summary for Sitaxentan

Top disease conditions for Sitaxentan
Top clinical trial sponsors for Sitaxentan

See all Sitaxentan clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.